Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 11

1.

Radiolabeled high affinity peptidomimetic antagonist selectively targets alpha(v)beta(3) receptor-positive tumor in mice.

Jang BS, Lim E, Hee Park S, Shin IS, Danthi SN, Hwang IS, Le N, Yu S, Xie J, Li KC, Carrasquillo JA, Paik CH.

Nucl Med Biol. 2007 May;34(4):363-70.

PMID:
17499725
2.

Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects.

Cai W, Shin DW, Chen K, Gheysens O, Cao Q, Wang SX, Gambhir SS, Chen X.

Nano Lett. 2006 Apr;6(4):669-76.

PMID:
16608262
3.

Integrin function and signaling as pharmacological targets in cardiovascular diseases and in cancer.

Paulhe F, Manenti S, Ysebaert L, Betous R, Sultan P, Racaud-Sultan C.

Curr Pharm Des. 2005;11(16):2119-34. Review.

PMID:
15974963
4.

Synthesis, in vitro, and in vivo characterization of an integrin alpha(v)beta(3)-targeted molecular probe for optical imaging of tumor.

Burnett CA, Xie J, Quijano J, Shen Z, Hunter F, Bur M, Li KC, Danthi SN.

Bioorg Med Chem. 2005 Jun 1;13(11):3763-71.

PMID:
15863003
5.

The role of integrins in tumor angiogenesis.

Hwang R, Varner J.

Hematol Oncol Clin North Am. 2004 Oct;18(5):991-1006, vii. Review.

PMID:
15474331
6.

Radiolabeled tracers for imaging of tumor angiogenesis and evaluation of anti-angiogenic therapies.

Haubner R, Wester HJ.

Curr Pharm Des. 2004;10(13):1439-55. Review.

PMID:
15134568
7.

Integrins: roles in cancer development and as treatment targets.

Jin H, Varner J.

Br J Cancer. 2004 Feb 9;90(3):561-5. Review.

8.

Role of integrins in cell invasion and migration.

Hood JD, Cheresh DA.

Nat Rev Cancer. 2002 Feb;2(2):91-100. Review.

PMID:
12635172
9.

Molecular imaging in living subjects: seeing fundamental biological processes in a new light.

Massoud TF, Gambhir SS.

Genes Dev. 2003 Mar 1;17(5):545-80. Review. No abstract available.

10.

Tumor regression by targeted gene delivery to the neovasculature.

Hood JD, Bednarski M, Frausto R, Guccione S, Reisfeld RA, Xiang R, Cheresh DA.

Science. 2002 Jun 28;296(5577):2404-7.

11.

Nonpeptide alpha(v)beta(3) antagonists. 1. Transformation of a potent, integrin-selective alpha(IIb)beta(3) antagonist into a potent alpha(v)beta(3) antagonist.

Duggan ME, Duong LT, Fisher JE, Hamill TG, Hoffman WF, Huff JR, Ihle NC, Leu CT, Nagy RM, Perkins JJ, Rodan SB, Wesolowski G, Whitman DB, Zartman AE, Rodan GA, Hartman GD.

J Med Chem. 2000 Oct 5;43(20):3736-45.

PMID:
11020288

Supplemental Content

Support Center